U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
REGDANVIMAB
INN  
Official Name English
CT-P59
Preferred Name English
Regdanvimab [WHO-DD]
Common Name English
CTP-59
Code English
IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL CT-P59 .GAMMA.-1 CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CT-P59 .LAMBDA.-CHAIN, DIMER
Common Name English
regdanvimab [INN]
Common Name English
CTP59
Code English
Code System Code Type Description
FDA UNII
I0BGE6P6I6
Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025
PRIMARY
SMS_ID
300000023100
Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025
PRIMARY
INN
11883
Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025
PRIMARY
NCI_THESAURUS
C177084
Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025
PRIMARY
CAS
2444308-95-4
Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025
PRIMARY
WIKIPEDIA
Regdanvimab
Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025
PRIMARY
ACTIVE MOIETY
REGDANVIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966